Fax: (011) 54-11 49640504
Results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation expert survey
Article first published online: 3 OCT 2008
Copyright © 2008 American Cancer Society
Supplement: Guidelines for International Breast Health and Cancer Control–Implementation
Volume 113, Issue Supplement 8, pages 2359–2365, 15 October 2008
How to Cite
Cazap, E., Buzaid, A. C., Garbino, C., de la Garza, J., Orlandi, F. J., Schwartsmann, G., Vallejos, C., Guercovich, A. and on behalf of the Latin American and Caribbean Society of Medical Oncology (2008), Breast cancer in Latin America. Cancer, 113: 2359–2365. doi: 10.1002/cncr.23834
Complete financial disclosures are presented at the end of this article.
Advisory Board: Eduardo Cazap, MD; Reinaldo Chacon, MD; Andres Guercovich MD; Elizabeth Mickiewicz, MD; Julia Widacovich, MD.
Opinion Leaders: Argentina: Bella Santiago, Block Carlos, Bustos Jorge, Capizzano Laura, Cazap Eduardo, Chacón Reinaldo, Del Castillo Rene Atilio, Gago Eduardo, Giacomi Nora, Jovtis Silvia, Langhi Mario, Leone Bernardo, Matwiejuc Mario Jorge, Mickiewicz Elizabeth, Morgado Cresta Carlos, Nuñez de Pierro Anibal, Reñe Juan,Taber Rogelio, Viniegra María; Bolivia: Fonseca Fernandez Lazaro, Paniagua Leon Carlos Felipe, Sitic Vargas Pablo; Brazil: Barros Alfredo Carlos S. D., Barrios Carlos Henrique, Froimtchuk Miguel, Gil Roberto, Menke Carlos Enrique, Murad André, Rufo de Freitas Junior, Salvajoli Joao Victor, Schwartzmann Gilberto, Simon Sergio, Vinholes Jeferson; Colombia: Caicedo José, Godoy Javier, Manni Raimundo, Ortiz Santa Cruz Carlos Alberto, Quintero Elías, Robledo José Fernando, Velásquez Andrés; Chile: Baeza Mario, Hepp Rodrigo, Muller Bettina, Orlandi Francisco, Orlandi Luis, Ramirez Augusto León, Vinés Eugenio; Honduras: Bejarano Cáceres Suyapa Aurora, Bulnes Molina Ricardo Ernesto, Maldonado Manuel, Segura Galdamez Ismael Arturo; Mexico: Alaniz Camino Francisco, Barroso Bravo Sinuhé, Cervantes Sanchez María Guadalupe, De la Cruz Vargas Jhony Alberto, De la Garza Jaime, Erazo Aura, Gonzalez Danés Horacio, Lopez Granel Carlos, Mohar Alejandro, Muñoz Gonzalez David Eduardo, Ocampo LeRoyal Rolando, Rodríguez Vidal Carlos, Ruiz Martinez Hermilo, Sanchez Basurto Carlos; Panama: Lopez Roberto Ivan, Pereyra Ricardo, Villareal Anibal; Paraguay: Duarte Jose, Gauna Cinthia, Gomez Graciela, Guggiari Gustavo, Sforza Silvia; Peru: Chong Jorge Leon, Gomez Henry, Pinillos Ashton Luis Vicente, Vallejos Carlos, Velarde Raul, Vidaurre Tatiana; Uruguay: Aizen Bernardo, Garbino Carlos, Guericke Matilde, Kasdorf Pedro, Laviña Raul, Lombardo Karina; Venezuela: Ferri Nicasio Nino, Gomez Alvaro, Hernandez Gerardo, Khalek Yihad, Montesino Carlos, Rebolledo Morella, Torres Strauss Luis.
- Issue published online: 3 OCT 2008
- Article first published online: 3 OCT 2008
- Manuscript Accepted: 24 JUN 2008
- Manuscript Received: 10 JUN 2008
- The Breast Cancer Research Foundation
- Latin America;
- expert survey;
- breast cancer
The incidence of breast cancer in Latin American countries is lower than that in more developed countries, whereas the mortality rate is higher. These differences probably are related to differences in screening strategies and access to treatment. Population-based data are needed to make informed decisions. A 65-question telephone survey that included 100 breast cancer experts from 12 Latin American countries was conducted in 2006 as an exploratory analysis of the current state of breast cancer treatment in these regions at both at the country level and at the center level. Greater than 90% of countries had no national law or guideline for mammography screening. The access rate to mammography was 66.3% at the country level and 47% at the center level. Variation in care based on level (country vs center) was indicated for the timing of treatment after diagnosis, timing from initial diagnosis to treatment, and the time from surgery to initial chemotherapy. However, the more sophisticated diagnostic testing for hormone receptors and biomarkers were available at most centers (>80%), and, overall, nearly 80% of patients started treatment within 3 months of diagnosis. Variation in care between breast cancer care at the center level versus the country level indicated a need for national cancer care programs. Alternative data collection strategies for understanding the state of breast cancer control programs in developing countries can help identify areas of improvement. Cancer 2008;113(8 suppl):2359–65. © 2008 American Cancer Society.